SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-24-098707
Filing Date
2024-09-10
Accepted
2024-09-10 21:04:24
Documents
1
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2423757-1_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2423757-1_4aseq1.xml 4/A 4636
  Complete submission text file 0001104659-24-098707.txt   6324
Mailing Address 110 HARTWELL AVENUE LEXINGTON MA 02173
Business Address
PALMISANO ROBERT J (Reporting) CIK: 0001138646 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-40021 | Film No.: 241291324
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Issuer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)